CPRX

NASDAQ · Biotechnology

Catalyst Pharmaceuticals Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$31.15

-0.02 (-0.05%)

As of May 9, 1:25 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 13 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +60.9% upside

Low Target $36.48

Average Target $50.13

High Target $69.47

Current Price $31.15

Current
$31.15

Target
$50.13

$36.48 $50.13 avg $69.47

Scenario Analysis

Bear Case

$36.48

17.1%

Low target

Base Case

$50.13

+60.9%

Avg target

Bull Case

$69.47

+123.0%

High target

Risk/Reward

7.2x

Highly favorable

Price in Context

52-Week High

$32.56

-4.3% from high

52-Week Low

$19.05

+63.5% from low

50-Day SMA

$23.76

+31.1% vs SMA

200-Day SMA

$22.30

+39.7% vs SMA

RSI (14)

48.5

Neutral

Target vs 52W High

$50.13

+54.0% vs high

Next Earnings Report

May 13, 2026

until earnings

EPS Est: $0.50

Earnings in 3 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	72%	$257.58	+27.8%
AMGN Amgen Inc	Hold	43	49%	$190.87	-42.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+176.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-19.5%
INSM Insmed Inc	Strong Buy	26	96%	$143.40	+41.5%